Costs of multimorbidity in older adults are climbing faster than its disability toll, and study authors say policy should ...
October's FDA approvals brought notable advances beyond oncology, adding new treatment options in allergy and immunology, ...
PBM reform, Medicare Advantage exits, and the 340B rebate pilot are reshaping drug access. Here is what payers need to know ...
UChicago Medicine’s Obada Shamaa, MD, PhD, discusses why bronchiectasis is underrecognized and how to personalize airway ...
Bispecific programs differ by practice size, but shared core components can guide adaptation, experts said at a webinar for ...
A gradient boosting model identified MASLD in lean adults with an AUC of 0.779, using 8 routine clinical measurements.
Pharmacists are moving beyond order verification into patient education, adverse effect mitigation, and parts of toxicity ...
Meta-analysis suggests off-label upadacitinib drives major alopecia areata hair regrowth and SALT score gains, but phase 3 ...
Kidney Week 2026 brought strong IgAN data, looked back on 5 years of value-based kidney care, and highlighted evidence of ...
Bipolar disorder often goes undiagnosed for years, and clinicians need to separate mood episodes from normal emotions and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results